MAIA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
8.3M
+19.7%
6.9M
+61.0%
4.3M
-53.9%
9.4M
+81.2%
5.2M
R&D
5.6M
+60.0%
3.5M
+87.3%
1.9M
-70.4%
6.4M
+104.4%
3.1M
SG&A
2.7M
-21.8%
3.4M
+40.6%
2.4M
-18.9%
3.0M
+46.1%
2.1M
Operating Income
-8317251
-19.7%
-6949929
-61.0%
-4317272
+53.9%
-9360926
-81.2%
-5166058
EBITDA
-8317251
-19.7%
-6949929
-61.0%
-4317272
+53.9%
-9360926
-81.2%
-5166058
Net Income
-7943587
-24.7%
-6369652
-75.5%
-3628762
+59.2%
-8903189
-66.5%
-5346963
EPS (Basic)
$-0.13
+7.1%
$-0.14
-40.0%
$-0.10
+63.0%
$-0.27
-50.0%
$-0.18
EPS (Diluted)
$-0.13
+7.1%
$-0.14
-40.0%
$-0.10
+63.0%
$-0.27
-50.0%
$-0.18
Shares (Diluted)
60.8M
+34.5%
45.2M
+21.3%
37.3M
+12.2%
33.2M
+9.6%
30.3M
MAIA Biotechnology (MAIA) โ€” Financials